ATA3219
ATA3219-AEC-104
Phase 1 small_molecule terminated
Quick answer
ATA3219 for Lupus Nephritis is a Phase 1 program (small_molecule) at Atara Biotherapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Atara Biotherapeutics
- Indication
- Lupus Nephritis
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- terminated